Homburger advised Roche on the deal, while Simpson Thacher represented the initial purchasers.
Roche Holdings, Inc. successfully completed its issuance of USD 500 m 0.450% Notes due 2024, USD 650 m 0.991% Notes due 2026 and USD 350 m Floating Rate Notes due 2024, which are irrevocably and unconditionally guaranteed by Roche Holding Ltd.
Roche Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides pharmaceutical and diagnostic solutions including advanced DNA tests, diabetes monitoring supplies, and point-of-care diagnostics.
The Homburger team advising Roche comprised Jürg Frick (Picture) and Dieter Grünblatt as well as Lee Saladino and Sofiya Shavlak.
The Simpson Thacher team advising the initial purchasers included Mark Brod, Pieter Lavens and Melchor Alvarez de Mon (Capital Markets); Michael R. Isby and Vanessa Burrows (Corporate); Alysha Sekhon and Bobbie Burrows (IP); and Jonathan Cantor and Suzy Yaster (Tax).
Law Firms: Homburger;